Trial
NCT03178201
TGR1202 in Relapsed and Refractory Follicular Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
TG Therapeutics, Inc.
Condition
Follicular Lymphoma
Intervention
TGR-1202
Why stopped
PI left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-16